Stocktoria
Sanofi SAN.PA
Sanofi (SAN.PA) earns a Piotroski F-score of 7/9 (strong financial health). It pays a dividend yielding 5.31% (safety: stretched). FY2025 revenue was $46.7B at a 16.7% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 23 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
FAQ
Is SAN.PA financially healthy?
Sanofi's Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak).
Does SAN.PA pay a dividend, and is it safe?
Yes. Sanofi pays a dividend yielding about 5.31% with a 61.1% payout ratio, rated “stretched” for safety.
How profitable is SAN.PA?
In FY2025, Sanofi had a net margin of 16.7% and a return on equity of 10.9%.
Source: company filings via Yahoo Finance · FR · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.